← Browse by Condition
Medical Condition
metastatic solid tumor
Total Trials
11
Recruiting Now
11
Trial Phases
Phase 1, Phase 2, Phase 1, Phase 2
ClinicalMetric tracks all active clinical trials for metastatic solid tumor sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.
Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.
Frequently Asked Questions — metastatic solid tumor Clinical Trials
How many clinical trials are currently recruiting for metastatic solid tumor?
ClinicalMetric currently tracks 11 actively recruiting clinical trials for metastatic solid tumor, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 11. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for metastatic solid tumor?
metastatic solid tumor research spans Phase 1 (10 trials), Phase 2 (2 trials). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a metastatic solid tumor clinical trial?
Eligibility criteria for metastatic solid tumor trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 1 10
Phase 2 2
Top Sponsors
1 trial
1 trial
1 trial
1 trial
1 trial
Recruiting Clinical Trials
NCT06302621 Phase 1
Recruiting
Enrollment
70 pts
Location
United States
Sponsor
Massachusetts General Hospital
NCT06358677 Phase 2
Recruiting
Enrollment
25 pts
Location
United States
Sponsor
University of Utah
NCT05983523 Phase 1
Recruiting
Enrollment
54 pts
Location
Taiwan
Sponsor
PharmaEngine
NCT06778863 Phase 1
Recruiting
Enrollment
90 pts
Location
United States
Sponsor
Clasp Therapeutics, Inc.
NCT05898399 Phase 1, Phase 2
Recruiting
Enrollment
181 pts
Location
United States, Spain
Sponsor
Artios Pharma Ltd
NCT07638371 Phase 1
Recruiting
Enrollment
16 pts
Location
United States
Sponsor
Memorial Sloan Kettering Cance...
NCT06163391 Phase 1
Recruiting
Enrollment
40 pts
Location
United States, Belgi...
Sponsor
SOTIO Biotech AG
NCT06108050 Phase 1
Recruiting
Enrollment
177 pts
Location
United States
Sponsor
Jazz Pharmaceuticals
NCT06952010 Phase 1
Recruiting
Enrollment
303 pts
Location
United States
Sponsor
Exelixis
NCT06577987 Phase 1
Recruiting
Enrollment
220 pts
Location
United States
Sponsor
Circle Pharma
NCT06561685 Phase 1
Recruiting
Enrollment
340 pts
Location
United States, Franc...
Sponsor
Eli Lilly and Company
Related Conditions
advanced solid tumor (10) unresectable solid tumor (3) lung cancer (2) solid tumor (2) cholangiocarcinoma (1) locally advanced solid tumor (1) colorectal adenocarcinoma (1) pancreatic adenocarcinoma (1) ovarian cancer (1) breast cancer (1) head and neck squamous cell carcinoma (1) prostate cancer (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: July 2026 · Data Methodology